MedTrace Logo

Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning

NCT07526662 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-04-13

No results posted yet for this study

Summary

This is a prospective observational cohort study conducted at Beijing Anzhen Hospital. The study aims to establish reference ranges of heart sound and electrocardiogram (ECG) parameters for both mothers and fetuses. It seeks to develop early warning models for maternal adverse cardiac events, fetal congenital heart disease progression, and autoimmune-related fetal heart block, thereby building a comprehensive maternal-fetal integrated risk stratification system.

Conditions

  • Pregnancy-Associated Heart Disease
  • Fetal Congenital Heart Disease
  • Autoimmune-Related Fetal Heart Block
  • Perinatal Adverse Events

Sponsors & Collaborators

  • Yihua He,MD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-05-31
Completion
2028-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07526662 on ClinicalTrials.gov